Screening for renal impairment in viral hepatopathy B: it is time to begin

Mona Boudabbous; Fatma Bouzid; Ikram Agrebi; Héla Gdoura; Lassad Chtourou; Manel Moalla; Leila Mnif; Ali Amouri; Khaoula Kammoun; N Tahri

doi:10.2144/fsoa-2023-0019

Screening for renal impairment in viral hepatopathy B: it is time to begin

Future Sci OA. 2023 Jul 6;9(9):FSO886. doi: 10.2144/fsoa-2023-0019. eCollection 2023 Oct.

Authors

Mona Boudabbous^{1

2}, Fatma Bouzid², Ikram Agrebi^{3

2}, Héla Gdoura^{1

2}, Lassad Chtourou^{1

2}, Manel Moalla^{1

2}, Leila Mnif^{1

2}, Ali Amouri^{1

2}, Khaoula Kammoun^{3

2}, N Tahri^{1

2}

Affiliations

¹ Gastroenterology Department, Hédi Chaker Hospital, Sfax, Tunisia.
² Department medecine B, Medecin Sfax University, Sfax university, Sfax, Tunisia.
³ Nephrology Department, Hédi Chaker Hospital, Sfax, Tunisia.

Abstract

Aim: The aim of this study was to assess the value of routine screening for renal damage in cases of B viral infection, by looking for proteinuria and elevated creatinemia.

Materials & methods: We investigate the frequency and associated factors of renal impairment in patients with viral B hepatopathy.

Results: Pathological albuminuria was confirmed in 44.73%. The chronic kidney disease with slightly decreased filtration rate was found in 21.05%. In multivariate analysis, only BMI was an independent factor for pathological albuminuria (p = 0.013) and only age was an independent predictor of chronic kidney disease (p = 0.056).

Conclusion: Urine dipstick and creatinemia are useful for routine screening in viral B hepatopathy especially in the elderly and overweight.

Keywords: albuminuria; hepatitis B; renal failure.